Asthma guidance conversationPosted on: 4 Apr 2018
The asthma guidelines from BTS/SIGN and NICE present service providers with conflicting advice. To FeNO test or not to FeNO test? When can trials of treatment be used as a diagnostic tool? Are LABAs or LTRAs the first choice add-on therapy? Will referrals to secondary care increase as a result of the new guidelines? Where must the commissioning community invest in order to ensure a quality respiratory service?
Here, two experts explore these contradictions, and propose a way forward.
- Duncan Keeley, GP and Executive Committee Policy Lead for PCRS.
- Liz Wilson, Respiratory Specialist Nurse Prescriber.